We have a personalized vaccine that's loaded with all antigens expressed in tumors.
NW does not undertake sequencing (or the other steps needed) to identify neoantigens. As for tumour-associated antigens, such as cancer-testis, T-cells will lack adequate specificity and/or affinity, so have very little, to no activity.
Why do you keep coming here promoting your own investments? These are off topic shilling posts not relevant to NWBO.
Again, the company is private, and I was using them as an example.